The Board of Directors for Pyxis Oncology includes a diverse group of experienced biotechnology executives, medical experts, and independent leaders. Key members guiding corporate governance and clinical strategy include John Flavin (serving as Chair of the Board), Thomas Civik (Interim Chief Executive Officer and Director), Darren Cline, Dr. Jakob Dupont, Dr. Freda Lewis-Hall, Dr. Rachel Humphrey, Michael A. Metzger, and Dr. Santhosh Palani, alongside specialized scientific and technical advisory board members.